Immune-Onc Therapeutics
Dave Chenn is the current director at Immune-Onc Therapeutics. Dave previously worked at the China Century Group, Inc. from March 2005 to December 2017, where they were the founder and chairman. Before that, they were at Oracle from January 1999 to December 2005 as an industry director.
Dave Chenn holds a Master of Business Administration from the University of Chicago and a Bachelor of Science in Engineering from Beijing Institute of Technology.
This person is not in the org chart
This person is not in any offices
Immune-Onc Therapeutics
Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.